XLO Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Xilio Therapeutics Inc

Watchlist Manager

Watchlist

Price: 8.33 USD -0.24%

Market Cap: $48.1m

X	Xilio Therapeutics Inc NASDAQ:XLO	US
	California Water Service Group NYSE:CWT	US
	Geberit AG F:GBRF	CH
	Dabur India Ltd BSE:500096	IN
	Tongwei Co Ltd SSE:600438	CN
	Perrigo Company PLC NYSE:PRGO	IE
	ARMOUR Residential REIT Inc NYSE:ARR	US
	Macy's Inc NYSE:M	US
R	Rajthanee Hospital PCL SET:RJH	TH
	Cal-Maine Foods Inc NASDAQ:CALM	US
	J B Hunt Transport Services Inc NASDAQ:JBHT	US
	Italian Wine Brands S.P.A. MIL:IWB	IT
D	Dowlais Group Plc LSE:DWL	UK
	Smith & Nephew PLC LSE:SN	UK
T	Tharisa PLC JSE:THA	CY
	Ningbo Tuopu Group Co Ltd SSE:601689	CN

Profitability Summary

Xilio Therapeutics Inc's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Low Gross Margin

Low 3Y Average Gross Margin

Negative Operating Margin

-96%

Negative 3Y Average Operating Margin

-912%

Negative Net Margin

-80%

Negative 3Y Average Net Margin

-897%

Negative Free Cash Flow Margin

-13%

Negative 3Y Average Free Cash Flow Margin

-192%

Negative ROE

-133%

Negative 3Y Average ROE

Negative 3Y Average ROIC

-392%

ROIC is Increasing

-549% > -309%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.